CABA
Cabaletta Bio, Inc.Healthcare$2.96
◆ Neutral
Mkt Cap: $329.5M|Float: 91.2M|SI: 20.9%|DTC: 7.0
Data as of market close Apr 2, 2026
IV Rank
53
IV Pctl
44%
HV 20d
65.6%
52W Range
$1-$4
ATR(14)
$0.24
Exp. Move
±39.7%
P/C Ratio
0.02
Earnings
May 14
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
CABA Key Options Data
- IV Rank
- 52.9%
- Total GEX
- $0.00B
- Total DEX
- $3.8M
- Max Pain
- $2.50
- Expected Move
- ±39.7%
- Put/Call OI
- 0.02
- Net Premium
- $-0.1M
- Spot Price
- $2.96
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.17 | ±39.7% | $1.79 | $4.14 |
| 2026-05-15 | 43 | ±$1.50 | ±50.7% | $1.46 | $4.46 |
| 2026-08-21 | 141 | ±$1.85 | ±62.5% | $1.11 | $4.81 |
| 2026-09-18 | 169 | ±$1.82 | ±61.7% | $1.14 | $4.79 |
| 2026-11-20 | 232 | ±$1.20 | ±40.5% | $1.76 | $4.16 |
| 2027-01-15 | 288 | ±$2.47 | ±83.6% | $0.49 | $5.44 |
Explore CABA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.